from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2330c/lppP

LFCtreatmentdescriptionclass of inhibitor

-0.144

Amikacinug/mL Amikacintranslation

-0.163

Cap5-10ug/mL Capreomycintranslation

0.197

Rox10-50 ug/mL Roxithromycintranslation

0.047

SM2-5 ug/mL Streptomycintranslation

1.130

Tet5-10 ug/mL Tetracyclinetranslation

0.001

Rif0.2-5ug/mL Rifampicintranscription

-0.167

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.175

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.792

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.018

CPZ10-50 ug/mL Chlorpromazinerespiration

0.873

Clofazimine10-13 ug/mL Clofaziminerespiration

0.584

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.261

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.581

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.340

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.852

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.538

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.277

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.841

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.032

KCN5-20 ug/mL Potassium cyaniderespiration

0.989

NaN30.2-2 mM Sodium aziderespiration

0.450

Nigericin50 uM Nigericinrespiration

1.165

TRC10-150 ug/mL Triclosanrespiration

-0.137

TRZ10-25 ug/mL Thioridazinerespiration

1.160

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.223

menadione6-10 ug/mL Menadionerespiration

0.002

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.200

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.038

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.120

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.571

NRP_1Non-replicating persistence stage 1dosRassociated

-0.110

Amp0.2mg/mL AmpicillincellWall

-0.077

Cephalexin20-100 ug/mL CephalexincellWall

-0.011

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.543

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.076

EMB10-20 ug/mL EthambutolcellWall

-0.477

Eta12-40 ug/mL EthionamidecellWall

-0.524

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.600

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.203

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.325

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.244

BZA0.12 mg/mL BenzamidearomaticAmides

-0.259

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.742

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.240

H2O24 mM hydrogen peroxideDNAdamaging

0.035

Levo10 ug/mL LevofloxacinDNAdamaging

-0.974

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.526

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.292

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.301

UVUV-irradiationDNAdamaging

0.195

ARP41-4 ug/mL Antitubercular compound ARP4?

0.022

Antimycin12.5-50 ug/mL Antimycin A?

-0.051

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.126

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.465

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.453

PA8240.2-2 ug/mL PA-824?

0.531

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.291

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.538

Verapamil50 uM Verapamil?

-0.225

mercaptoethanol2 mM 2-Mercaptoethanol?

0.007

methoxatin10-20 ug/mL Methoxatin?